PHAT

Phathom Pharmaceuticals Inc

PHAT.US phathompharma.com + Research + Basket
CIK 0001783183
Employees 371
Phone 877 742 8466
Fiscal year end December
IPO Oct 25, 2019
Address 100 Campus Drive, Florham Park, NJ, United States, 07932
6.28
+0.29 (+4.84%)
USD · NASDAQ
52-week range
5.02
18.31
Trading at 10% of the 52-week range
Market Cap
480.55M
P/E Ratio
0.00
Forward P/E
5.40
Book Value
-4.30
Div. Yield
N/A
% Institutions
94.39%
% Insiders
4.64%

1 Year

-53.6%

3 Year

-30.1%

10 Year

-74.5%
Description

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Actions

Add an action for PHAT.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Steven L. Basta M.B.A. CEO, President & Director 1966
Mr. David A. Socks Co-Founder 1975
Dr. Azmi Nabulsi M.D., M.P.H. Co-Founder 1960
Mr. Sanjeev Narula Chief Financial & Business Officer 1961
Ms. Anne Marie Cook Esq., J.D. Chief Legal Officer & Corporate Secretary 1962
Mr. Jonathan Bentley Senior VP and Head of Sales, Operations & Training NA
Mr. Robert Breedlove VP of Finance & Principal Accounting Officer NA
Mr. Eric Sciorilli Director of Business Development & Investor Relations NA
Mr. Bill Aprea J.D. Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Nov 03, 2025 Robert Charles Breedlove N/A Sale 524.00 $13.51 $7.08K SEC
Sep 05, 2025 Robert Charles Breedlove N/A Sale 461.00 $12.09 $5.57K SEC
Jul 16, 2025 Robert Charles Breedlove N/A Sale 1.69K $8.36 $14.15K SEC
May 21, 2025 James N Topper N/A Purchase 3.78K $3.86 $14.59K SEC
May 06, 2025 Asit Parikh N/A Purchase 5.00K $2.60 $13.00K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Frazier Life Sciences Management, L.P. 12.47M Jun 30, 2026 15.41% $2.95 0.00%
Medicxi Ventures Management (Jersey) Ltd 7.46M Jun 30, 2026 9.23% $45.65 0.00%
BlackRock Inc 4.53M Jun 30, 2026 5.59% $0.00 11.40%
Amvescap Plc. 4.03M Jun 30, 2026 4.98% $0.00 -6.76%
The Carlyle Group Inc 3.50M Jun 30, 2026 4.32% $0.38 0.00%
Millennium Management LLC 3.38M Jun 30, 2026 4.17% $0.01 -16.08%
Vanguard Capital Management, LLC 2.66M Jun 30, 2026 3.28% $0.00 2.84%
GW&K Investment Management, LLC 2.17M Jun 30, 2026 2.68% $0.18 52.48%
Franklin Templeton Inc 1.97M Jun 30, 2026 2.44% $0.00 98.17%
NEA Management Company, LLC 1.96M Jun 30, 2026 2.42% $1.34 0.00%
683 Capital Management LLC 1.85M Mar 31, 2026 2.29% $1.07 3.64%
The Goldman Sachs Group Inc 1.78M Jun 30, 2026 2.20% $0.00 183.94%
State Street Corp 1.59M Jun 30, 2026 1.96% $0.00 14.38%
Catalys Pacific LLC 1.49M Jun 30, 2026 1.85% $7.06 0.00%
Delaware Management Holdings Inc 1.46M Jun 30, 2026 1.81% $0.02 21.35%
Geode Capital Management, LLC 1.32M Jun 30, 2026 1.63% $0.00 -0.93%
Wasatch Advisors LP 1.31M Jun 30, 2026 1.62% $0.09 -2.51%
Ensign Peak Advisors Inc 1.05M Jun 30, 2026 1.30% $0.02 -35.38%
Propel Bio Management LLC 1.05M Jun 30, 2026 1.30% $5.96 24.85%
Point72 Asset Management, L.P. 1.02M Jun 30, 2026 1.26% $0.01 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 2.01M 2.48% ▲ 0.00% Sep 30, 2026
2 Strategic Advisers U.S. Total Stock 1.36M 1.68% ▲ 0.00% Aug 31, 2026
3 iShares Russell 2000 ETF 1.29M 1.59% ▼ 1.14% Sep 30, 2026
4 Franklin Biotechnology Discv A(acc)USD 938.93K 1.16% ▲ 0.00% Sep 30, 2026
5 Franklin Small Cap Growth Adv 827.07K 1.02% ▲ 0.00% Sep 30, 2026
6 State Street® SPDR® S&P® PhrmctlsETF 816.18K 1.01% ▼ 1.23% Sep 30, 2026
7 Wasatch Micro Cap 806.56K 1.00% ▲ 0.00% Jun 30, 2026
8 MEDICAL BioHealth EUR Acc 781.82K 0.97% ▲ 0.02% Aug 31, 2026
9 HSBC GIF Glb Eq Sust Hlthcare AC USD 700.00K 0.87% ▲ 0.00% Jul 31, 2026
10 Columbia Small Cap Value Discv A 557.78K 0.69% ▲ 0.63% Aug 31, 2026

Financial Highlights

▼
Market Cap: $480.55M
EBITDA: $-40.13M
Book Value: $-4.30
Earnings/Share: $-1.26
Profit Margin: -41.34%
Operating Margin: -5.34%
ROA (TTM): -8.80%
ROE (TTM): -3,489.00%
Revenue (TTM): $239.66M
Revenue/Share (TTM): $3.06
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 88.00%

Valuation Metrics

Enterprise Value: $447.79M
Trailing P/E: 0.00
Forward P/E: 5.40

Shares Statistics

Shares Outstanding: 80.90M
Shares Float: 65.07M
% Insiders: 4.64%
% Institutions: 94.39%
Short % Float: 13.15%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$175.11M
Cost of Goods Sold
adjust
$-22.60M
Gross Profit
subtotal
$152.51M
SG&A
adjust
$-279.72M
R&D
adjust
$-32.78M
Operating Income
subtotal
$-159.99M
Other / Non-Operating Items
adjust
$-61.26M
Net Income
subtotal
$-221.25M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PHAT.US!